Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies-Reference-Cited by-同舟云学术

Pharmacological Characterization of a Novel 5-Hydroxybenzothiazolone-Derived β2-Adrenoceptor Agonist with Functional Selectivity for Anabolic Effects on Skeletal Muscle Resulting in a Wider Cardiovascular Safety Window in Preclinical Studies

Published:2019-02-28 Issue:2 Volume:369 Page:188-199
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Koziczak-Holbro Magdalena,Rigel Dean F.,Dumotier Bérengère,Sykes David A.,Tsao Jeffrey,Nguyen Ngoc-Hong,Bösch Julian,Jourdain Marie,Flotte Ludivine,Adachi Yuichiro,Kiffe Michael,Azria Moïse,Fairhurst Robin A.,Charlton Steven J.,Richardson Brian P.,Lach-Trifilieff Estelle,Glass David J.,Ullrich Thomas,Hatakeyama Shinji

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference53 articles.

1. β3-Adrenoceptors modulate left ventricular relaxation in the rat heart via the NO-cGMP-PKG pathway

2. In Vitro and in Vivo Pharmacological Characterization of 5-[(R)-2-(5,6-Diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (Indacaterol), a Novel Inhaled β2 Adrenoceptor Agonist with a 24-h Duration of Action

3. β-Adrenoceptor signaling in regenerating skeletal muscle after β-agonist administration

4. β 1- and β 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure;Brodde;Pharmacol Rev,1991

5. Anabolic effects of a non-myotoxic dose of the β2-adrenergic receptor agonist clenbuterol on rat plantaris muscle;Burniston;Muscle Nerve,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of G protein‐coupled receptor kinases (GRKs) in β₂‐adrenoceptor‐mediated glucose uptake;Pharmacology Research & Perspectives;2024-02

2. Inhaled formoterol impairs aerobic exercise capacity in endurance-trained individuals: a randomised controlled trial;ERJ Open Research;2023-01-26

3. Kidney targeting of formoterol containing polymeric nanoparticles improves recovery from ischemia reperfusion-induced acute kidney injury in mice;Kidney International;2022-11

4. Muscle hypertrophic effect of inhaled beta ₂ ‐agonist is associated with augmented insulin‐stimulated whole‐body glucose disposal in young men;The Journal of Physiology;2022-03-16

5. Design, Development, Physicochemical Characterization, and In Vitro Drug Release of Formoterol PEGylated PLGA Polymeric Nanoparticles;Pharmaceutics;2022-03-14